Onset of Efficacy of Long-Acting Psychostimulants in Pediatric Attention-Deficit/Hyperactivity Disorder

@article{Brams2008OnsetOE,
  title={Onset of Efficacy of Long-Acting Psychostimulants in Pediatric Attention-Deficit/Hyperactivity Disorder},
  author={Matthew Brams and A. Mao and R. Doyle},
  journal={Postgraduate Medicine},
  year={2008},
  volume={120},
  pages={69 - 88}
}
Abstract Background: Attention-deficit/hyperactivity disorder (ADHD) adversely impacts the educational achievement, mood and emotion processing, and interpersonal relationships of children and adolescents. Effective treatments include a number extended-release (ER) methylphenidate- (MPH) and amphetamine-based drugs. Some formulations release a comparatively larger bolus after dosing and can result in different onset and duration of efficacy. Objective: Provide an evidence-based description of… Expand
View on Taylor & Francis
ncbi.nlm.nih.gov
19 Citations
Highly Influential Citations
1
Background Citations
6

Paper Mentions

Blog Post
Lisdexamphetamine
New Drug Approvals
28 June 2017

19 Citations

Citation Type

Citation Type

Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
  • 61
Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
  • J. Najib
  • Medicine
  • Adolescent health, medicine and therapeutics
  • 2012
  • 7
  • PDF
Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
  • 7
  • Highly Influenced
Attention-Deficit Hyperactivity Disorder
  • 34
  • PDF
The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD
  • 20
Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients
  • 33
Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications
  • 5
Lisdexamfetamine Dimesylate
  • 23
Treatment strategies for ADHD: an evidence-based guide to select optimal treatment
  • 29
  • PDF
Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design
  • 31
...
1
2
...

References

SHOWING 1-10 OF 86 REFERENCES
Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting.
  • 42
New options in the pharmacological management of attention-deficit/hyperactivity disorder.
  • M. Olfson
  • Medicine
  • The American journal of managed care
  • 2004
  • 40
Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder.
  • 41
Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.
  • 57
Efficacy and Safety of Ritalin® LA™, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder
  • 74
Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.
  • 299
Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.
  • 323
ADouble-Blind, Placebo-Controlled Withdrawal Trial of Dexmethylphenidate Hydrochloride in Children with Attention Deficit Hyperactivity Disorder
  • 38
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
  • 1,025
  • PDF
Attention-deficit hyperactivity disorder
  • 1,237
  • PDF
...
1
2
3
4
5
...